Lindbrook Capital, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$5,000
+66.7%
1560.0%0.00%0.0%
Q2 2020$3,000
-40.0%
156
-50.9%
0.00%
-50.0%
Q1 2020$5,000
-54.5%
3180.0%0.00%
-50.0%
Q4 2019$11,000
+57.1%
3180.0%0.00%
+33.3%
Q3 2019$7,000
+16.7%
3180.0%0.00%
+50.0%
Q2 2019$6,000
-14.3%
3180.0%0.00%
-33.3%
Q1 2019$7,0000.0%3180.0%0.00%0.0%
Q4 2018$7,0003180.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders